APRIL 2026

NEWS & COLUMNS

6-7 NEWS
Lilly to acquire Centessa in $7.8bn deal; Gilead to acquire Tubulis in $5bn deal

8-9 NEWS
Novo Nordisk once-weekly insulin approved; Novartis to buy breast cancer treatment

11 DERMATOLOGY NEWS
AAD publishes new paediatric eczema guidelines; UCB presents psoriasis treatment data

12 DARWIN’S MEDICINE
When will marketing be taken seriously?

13 PARTNERSHIP HEALTH
Partnership health is framed around three core pillars

14 INTEGRATED INSIGHTS
The changing imperative for pharma leaders

15 VACCINE COMMS MATTER
When innovation is not enough

FEATURES

16-17 TUBERCULOSIS – THE SEARCH FOR A CURE
Tuberculosis is one of the most persistent infectious diseases in human history. Drug resistance is a significant problem and treatment requires an extended period of time – currently, at least six months – to completely eliminate the hardy infection

18-19 FINDING A CURE FOR LUPUS
The Lupus Research Alliance, the world’s largest private funder of lupus research, has launched Lupus Ventures, the first philanthropic venture fund dedicated to accelerating treatments and diagnostics for lupus and related autoimmune conditions

22-25 LEADING THROUGH PLATFORMS IN AN ERA BEYOND PRODUCTS
Platforms can be powerful sources of competitive advantage, but only when managed with strategic discipline and anchored in customer value

COMMUNIQUE
MARKETING & COMMS

28-29 THE BRIDGE BETWEEN WEIGHT LOSS DRUGS AND BEHAVIOUR CHANGE
With new product launches expected over the next five years, the defining market differentiator may not be in the compound, but in a companion behaviour change programme

32-33 AI + DATA IN CLINICAL TRIAL PLANNING
AI is becoming embedded in the business world, and the pharmaceutical industry is no exception. With its adoption, however, critical questions arise as to how it is implemented and the impact it can have

34-35 EUROPE’S NEXT HEALTH INNOVATION ENGINE
Across Europe, healthcare systems are attempting to modernise under enormous pressure, as demand continues to rise and expectations continue to shift

CAREERS & RECRUITMENT

36-38 APPOINTMENTS
Each month, we bring you the latest news on job changes in the pharma sector. This month, we are highlighting change at Biologos, IsomAB and Mestag Threrapeutics

6 LILLY TO ACQUIRE CENTESSA IN $7.8BN DEAL

8 NOVO NORDISK ONCE-WEEKLY INSULIN APPROVED

11 UCB PRESENTS PSORIASIS TREATMENT DATA

16 TB – THE SEARCH FOR A CURE

18 FINDING A CURE FOR LUPUS

28 THE BRIDGE BETWEEN WEIGHT LOSS DRUGS AND BEHAVIOUR CHANGE

22 LEADING THROUGH PLATFORMS

34 EUROPE’S NEXT HEALTH INNOVATION ENGINE